Andas 5 Holding Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANDAS 5 HOLDING, and what generic and branded alternatives to ANDAS 5 HOLDING drugs are available?
ANDAS 5 HOLDING has four approved drugs.
Summary for Andas 5 Holding
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Andas 5 Holding
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Andas 5 Holding | BACLOFEN | baclofen | TABLET;ORAL | 212378-001 | Oct 9, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Andas 5 Holding | CAPTOPRIL | captopril | TABLET;ORAL | 074677-002 | May 30, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Andas 5 Holding | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 075215-003 | Jul 29, 1999 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Andas 5 Holding | CAPTOPRIL | captopril | TABLET;ORAL | 074677-001 | May 30, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Andas 5 Holding | RAMELTEON | ramelteon | TABLET;ORAL | 215435-001 | Aug 24, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
